Discover
GELS
Gelteq Limited Ordinary Shares
0.61
1 x 0.59
30 x 0.64
bid
ask
+
0.02
3.41%
100 @ 04:00 PM
0.61 -0.00 (0.02%)
| Ytd | -23.76% | |
| 1y | -66.67% |
0.58
day range
0.62
0.39
52 week range
2.02
| Open | 0.59 | Prev Close | 0.59 | Low | 0.58 | High | 0.62 | Mkt Cap | 5.60M |
| Vol | 197.07K | Avg Vol | 3.71M | EPS | -0.50 | P/E | -1.22 | Forward P/E | N/A |
| Beta | -0.55 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.61 | 200-d Avg | 0.84 | 1yr Est | 0.00 |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|